Spectrum Pharmaceuticals, Inc. (SPPI) financial statements (2023 and earlier)

Company profile

Business Address 11500 S. EASTERN AVE., SUITE 240
HENDERSON, NV 89052
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:101180224204228158140
Cash and cash equivalents8946  227158140
Short-term investments1213431460  
Other undisclosed cash, cash equivalents, and short-term investments  193158   
Receivables 0030324030
Inventory, net of allowances, customer advances and progress billings   4694
Inventory   4694
Prepaid expense2410101044
Other undisclosed current assets121042613
Total current assets:104187244251278217191
Noncurrent Assets
Operating lease, right-of-use asset324
Property, plant and equipment04120101
Intangible assets, net (including goodwill)   130155182208
Goodwill   18181818
Intangible assets, net (excluding goodwill)   112137164190
Other noncurrent assets54410543021
Total noncurrent assets:81019140210212230
TOTAL ASSETS:112197263391487429421
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:41444162524842
Accounts payable33343245343027
Accrued liabilities 118997
Employee-related liabilities129810998
Other undisclosed accounts payable and accrued liabilities(4)(1)     
Debt  2 38  
Deferred compensation liability    587
Deferred revenue and credits436
Contract with customer, liability5
Other undisclosed current liabilities129201911622
Total current liabilities:535362861106676
Noncurrent Liabilities
Liabilities, other than long-term debt11911671715
Deferred revenue and credits000
Deferred tax liabilities, net  77
Other liabilities1191166107
Other undisclosed noncurrent liabilities   1620111117
Total noncurrent liabilities:119112126127132
Total liabilities:646373108136193208
Stockholders' equity
Stockholders' equity attributable to parent, including:48134190283351236213
Common stock0000000
Additional paid in capital1,0941,021918887837640552
Accumulated other comprehensive income (loss)(3)(2)(3)(4)16(2)(5)
Accumulated deficit(1,044)(885)(724)(600)(502)(403)(334)
Other undisclosed stockholders' equity attributable to parent      0
Total stockholders' equity:48134190283351236213
TOTAL LIABILITIES AND EQUITY:112197263391487429421

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues61 109128146137
Revenue, net128146163
Gain (loss) on disposition of assets for financial service operations61(13) 
Cost of revenue  (0)(19)(39)(62)(66)
Cost of goods and services sold    (32)(34)(38)
Gross profit:61(0)91898571
Operating expenses(148)(170)(141)(222)(186)(146)(137)
Other undisclosed operating income (loss)(6)(1)    26
Operating loss:(148)(170)(141)(131)(97)(62)(41)
Nonoperating income (expense)(11)(2)(4)11(11)(9)(10)
Other nonoperating income (expense)(11)(3)(9)1001(1)
Interest and debt expense   (3)(8)(10)(9)
Loss from continuing operations before equity method investments, income taxes:(158)(171)(145)(123)(116)(81)(60)
Other undisclosed income from continuing operations before income taxes   38109
Loss from continuing operations before income taxes:(158)(171)(145)(120)(108)(71)(50)
Income tax expense (benefit)(0)09(0)172(0)
Net loss:(158)(171)(135)(120)(91)(69)(51)
Other undisclosed net income (loss) attributable to parent(0)1023    
Net loss available to common stockholders, diluted:(159)(161)(113)(120)(91)(69)(51)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(158)(171)(135)(120)(91)(69)(51)
Comprehensive loss:(158)(171)(135)(120)(91)(69)(51)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)1223(2)184(4)
Comprehensive loss, net of tax, attributable to parent:(160)(159)(112)(123)(74)(65)(55)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: